Texas Oncology - Tyler — Tyler, Texas

Public research footprint of Texas Oncology - Tyler, compiled from the ClinicalTrials.gov public registry.

140

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Follicular Lymphoma · Breast Cancer · Relapsed/Refractory Diffuse Large B-cell Lymphoma · Metastatic Non Small Cell Lung Cancer

Recently updated registry entries

NCT07023627 — A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… (Recruiting)
NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Texas Oncology - Tyler?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.